Related Experiment Video

Updated: Jul 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer

Michelle Craig Barton1, Said Akli, Khandan Keyomarsi

  • 1Department of Biochemistry and Molecular Biology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Journal of Cellular Physiology
|September 27, 2006
PubMed

Insights

Loss of p53 tumor suppressor function allows deregulated cyclin E to drive cancer progression. Understanding these cell cycle control pathways is key to developing new cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Oncology

Background:

  • Cyclin E deregulation, particularly overexpression of short or low molecular weight (LMW) forms, contributes to oncogenesis.
  • Cyclin E promotes cell cycle progression into S-phase.
  • The tumor suppressor p53 normally opposes cyclin E activity through checkpoint activation or apoptosis.

Purpose of the Study:

  • To review the intersecting pathways of p53 and cyclin E in tumor development.
  • To elucidate how p53 loss enables cyclin E-driven tumor growth.
  • To identify potential therapeutic strategies by understanding these molecular networks.

Main Methods:

  • Literature review of molecular signaling pathways.
  • Analysis of cell cycle regulation mechanisms.
  • Examination of oncogenic deregulation in cancer.

Main Results:

  • Loss of p53 function provides an 'escape hatch' for tumor cells with cyclin E deregulation.
  • This loss permits avoidance of cell cycle arrest and apoptosis, facilitating unchecked tumor growth.
  • Intersections between p53 and cyclin E pathways are critical for cancer progression.

Conclusions:

  • Understanding the interplay between p53 and cyclin E is crucial for closing the 'escape hatch' in cancer.
  • Targeting these pathways may offer novel therapeutic avenues for cancer treatment.
  • Further research into cellular signaling networks is needed to combat tumor development.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...